chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She got her vaccine, she didn't notice anything, then not knowing when this happened, was feeling okay, she got a horrific pain to her head like a shock, and was reaching for the doorknob of her closet and had immediate pain in her head, and threw her backwards and hit her head on the floor.   She laid there a little while and got up.  They were locked down due to COVID and could not get up.  This same type of event happened two more times in 2 weeks time.  The pain was severe, and terrible.  She has been dealing with this for so long, and is tired of the pain as it is exhausting.  She has the headaches, and has head pain occasionally.  She is not the type to take pain medicine.  She told her doctor about the headaches when she had a routine APT.  He felt that it was due to her neck as she has had back and neck surgery in the past.  She dealt with that pain without any problems, but this is a different type of pain.  She kept telling him about the pain that goes down into her neck and shoulders, and he sent her to a doctor and ended up going to 4 doctors and the 4th one she saw talked to the nurse.  She went into his office, had a picture of her head on his computer and said that her brain looked great for her age.  She asked why she had terrific pain in her head 3 times in 2 1/2 weeks.  He prescribed Gabapentin 100 mg, which did help as far as being able to sleep at least 2-2 1/2 hours at night as she does not sleep good due to the pain in her head or in her neck.   During the day then her pain would be so bad like she did not take anything for it, it only helped her at night when she tried to sleep.  During the day she would have the terrific pains all day long.    She was given Tylenol for arthritis to take, then started having chest pains, but has to take it due to the pain.  Her hearing is worse since the shot, and her hair has been falling out, about 30-50 strands of hair a day.  She had her hair cut short, and now has flaking skin in her scalp, which she did not have any dandruff in the past before the vaccine, she also has itching scalp.   She is afraid that she will go bald.  She states that her head will get hot, back of her head and go to the crown of her head and feels like there are a million things running around in the back of her head.    She wished she would have never gotten the vaccines.    She also noticed that sometimes her hands and feet go numb, like they are asleep and tingle a little bit as well.
no adverse effects reported; patient was vaccinated with improperly stored MMR II; This spontaneous report has been received from a medical assistant, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided.  On 04-MAR-2019, the patient was vaccinated with improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (albumin status rHA) one dose, lot # R019391 with expiration date 05-JUL-2020 (frequency, route and anatomical location were not provided) which was reconstituted with sterile diluent (dose, frequency, route, lot number and expiration date were not provided) for prophylaxis. No adverse effects reported.  The temperature and time frame were unknown by reporter. There was previously temperature excursions and digital data logger was involved.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1906USA011469: US-009507513-1907USA010301: US-009507513-1907USA010302: US-009507513-1907USA010303: US-009507513-1907USA010304: US-009507513-1907USA010305: US-009507513-1907USA010306: US-009507513-1907USA010307: US-009507513-1907USA010308: US-009507513-1907USA010309: US-009507513-1907USA010310: US-009507513-1907USA010311: US-009507513-1907USA010312: US-009507513-1907USA010313: US-009507513-1907USA010314: US-009507513-1907USA010315: US-009507513-1907USA010316: US-009507513-1907USA010317: US-009507513-1907USA010318: US-009507513-1907USA010319: US-009507513-1907USA010320: US-009507513-1907USA010321: US-009507513-1907USA010322: US-009507513-1907USA010323: US-009507513-1907USA010324: US-009507513-1907USA010325: US-009507513-1907USA010326: US-009507513-1907USA010327: US-009507513-1907USA010328: US-009507513-1907USA010329: US-009507513-1907USA010330: US-009507513-1907USA010331: US-009507513-1907USA010332: US-009507513-1907USA010333: US-009507513-1907USA010334: US-009507513-1907USA010335: US-009507513-1907USA010336: US-009507513-1907USA010337: US-009507513-1907USA010338: US-009507513-1907USA010339: US-009507513-1907USA010340: US-009507513-1907USA010341: US-009507513-1907USA010342: US-009507513-1907USA010343: US-009507513-1907USA010344: US-009507513-1907USA010345: US-009507513-1907USA010346: US-009507513-1907USA010347: US-009507513-1907USA010348: US-009507513-1907USA010350: US-009507513-1907USA010351: US-009507513-1907USA010352: US-009507513-1907USA010353: US-009507513-1907USA010354: US-009507513-1907USA010355: US-009507513-1907USA010356: US-009507513-1907USA010357: US-009507513-1907USA010358: US-009507513-1907USA010359: US-009507513-1907USA010360: US-009507513-1907USA010361: US-009507513-1907USA010362: US-009507513-1907USA010363: US-009507513-1907USA010364: US-009507513-1907USA010365: US-009507513-1907USA010366: US-009507513-1907USA010367: US-009507513-1907USA010368: US-009507513-1907USA010369: US-009507513-1907USA010370: US-009507513-1907USA010371: US-009507513-1907USA010372: US-009507513-1907USA010373:
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. Information on the patient's concurrent conditions, medical history or concomitant therapy was not reported.  On or about 01-OCT-2013, the patient was inoculated with zoster vaccine live(ZOSTAVAX) (lot#, expiration date, dose, route of administration and anatomical location were not reported) by a healthcare provider at the medical office, for the long-term prevention of shingles and/or zoster-related conditions.        Subsequent to zoster vaccine live(ZOSTAVAX) inoculation, patient was treated on an unknown date at the medical office for shingles.  As a direct and proximate result of zoster vaccine live(ZOSTAVAX), patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future.   The outcome of shingles was unknown.
During night after vaccination pt was chilled, couldn't catch breath, arms went numb. Didn't take temp.  Didn't wake wife.  Felt better next morning.  Completely ok after that day.
fever, chills, cough, severe headache, nausea, body aches, mental confusion
Case completed Covid vaccine series 4/2/21, and was admitted to hospital 8/15/21 for Covid, and died of Covid on 8/18/21.
Hives; swelling; A spontaneous report was received from a pharmacist concerning a female patient participating who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced the serious event of swelling and hives.   The patient's medical history, as provided by the reporter, included an "extensive history of allergies" and history of taking diphenhydramine prior to influenza vaccination. No relevant concomitant medications were reported.   On 27 Dec 2020, approximately 7 minutes prior to the onset of the events, the patient received her first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.   On 27 Dec 2020, the patient was admitted to the hospital with swelling and hives occurring 7 minutes after the injection. She was admitted to the intensive care unit (ICU) overnight and stayed approximately 24 hours. She did not require intubation. Treatment for the event included an epinephrine drip.  On 30 Dec 2020, the hives and swelling returned. The patient planned to go to the hospital, but she was not sure if she would be admitted.   Action taken with mRNA-1273 in response to the events was not reported.   The events, swelling and hives, were considered not resolved.   The reporter did not provide assessment for the events of swelling and hives.; Reporter's Comments: This case concerns a female patient with an extensive history of allergies, who received their first of two planned doses of mRNA-1273 (Lot-# and expiration date -unknown), who experienced unexpected events of urticaria and swelling and hives on the same day, approximately 7 minutes after vaccination. The reporter did not provide the causality assessment for the events. Due to the temporal association between the events (urticaria and swelling) and the administration of the vaccine, a causal relationship cannot be excluded.
patient described pain in her left arm muscles, pain radiating into the back, pain in the ribs when she breaths
Left deltoid below the injection is hot, red, and inflamed. The area has spread from a baseball size spot to covering approximately 80% of his upper left arm. Day two appears to be less red. Redness is lessening as it spreads.
Several rashes have developed on the arm of the injection site of the second dose; This is a spontaneous report from a contactable consumer, the patient. A 79-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in left arm on 31Mar2021 at 15 hours as a single dose, for COVID-19 immunisation. Medical history included pre-diabetic. The concomitant medications included metformin (MANUFACTURER UNKNOWN) and atorvastatin (MANUFACTURER UNKNOWN) both for unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and the patient has not been tested for COVID-19. The patient previously received single dose of Pfizer vaccine in arm Left on 03Mar2021 at 12:45 hours. On 25Apr2021, the patient experienced several rashes that had developed on the arm of the injection site (vaccination site rash) following the second dose. The first sign of the rash had occurred during the week of 25Apr2021 and was still present at the time of this report. The rash had begun with a circular patch around where the shot was given and had spread down the arm which formed a circle around the middle of the forearm. The event had not resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the reported event was not recovered at the time of this report.   No follow-up attempts are possible. Information about lot number cannot be obtained.
Patient presented to the hospital 1/24/22 from hematologist office due to low HBG 7.1 without apparent bleeding.  History of GI bleed, takes iron supplements.  Presented due to progressively feeling worse, weak, lightheaded, exertional SOB.  + blood in stool.  Chest xray on 1/27 IMPRESSION:  1. Cardiomegaly and minimal vascular congestion of concern for minimal/early developing congestive heart failure.  Patient treated with Lasix and improving.  Pt treated for GI bleed - asymptomic for COVID; discharge 1/29/22.  Previously vaccinated Pfizer 2/10/21 & 3/3/21.  Discharged 1/29/22
Red, Painful, Swollen at injection site 2 inch circumference.  Fatigue. 650 mg Tylenol every 6 hours for 24 hours.
A report has been received from a Health Professional concerning an 11 year old, female subject, who had been receiving FLUMIST (INTRANASAL). FLUMIST (INTRANASAL) started on 06-Dec-2013. The patient experienced FEVER, LOW BACK PAIN and DIZZINESS which started on 12-Dec-2013. The patient recovered from the event of FEVER, LOW BACK PAIN and DIZZINESS on an unspecified date. The report was considered to be non-serious. The reporter considered that there was no causal relationship between FEVER and FLUMIST, LOW BACK PAIN and FLUMIST and DIZZINESS and FLUMIST. The Company Physician considered the events of fever, low back pain and dizziness to be causally unrelated with suspect drug of FLUMIST.
Ileocolic Intussusception Symptoms: Vomitting and blood in stool Time course: 12 hours. Was sent to Hospital - intussusception confirmed by abdominal ultasound. Air contrast enema reduced intussusception.
Vagal syncope, Pt hit nose on flood during fall which caused bruising and a moderate nose bleed. Incident happened about 5-10 minutes after the vaccine.
Skin rash and chemical burn.  Basically, took off my skin.  About the size of a dime.
Patient presented to the pharmacy stating that after she received the vaccine her shoulder was swollen, she had a 'knot' at the vaccine site, pain in the upper right arm, warmth, redness and itching. She states the symptoms are improving but she is still having itching at the infection site. She reports improvement with itching upon taking BENADRYL.
Weak knees; Dizzy; Shakes and chills; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (Weak knees), DIZZINESS (Dizzy) and CHILLS (Shakes and chills) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No adverse event history).    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced MUSCULAR WEAKNESS (Weak knees), DIZZINESS (Dizzy) and CHILLS (Shakes and chills). At the time of the report, MUSCULAR WEAKNESS (Weak knees), DIZZINESS (Dizzy) and CHILLS (Shakes and chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. Information about medical history or concurrent conditions was not provided. On 05-AUG-2014 the patient was vaccinated with an incorrect stored dose GARDASIL 0.5 ml, intramuscularly injection (frequency, lot number and expiration date were not provided), which had underwent a temperature excursion. Concomitant medications were not reported. No adverse effect was reported and there was no product quality complaint involved. This is one of several reports received from the same source. Additional information has been requested.
Arthralgia, Myalgia within hours of vaccination Chest palpitation with hr 100-140 for at least 3 hours and low grade fever Drank water, juice, and breathing exercise for tachycardia and hr went down from 120-140 to 100-110 Took tylenol and used ice packs for fever and body aches Had to be out of work the day after vaccination On day 3 almost complete recovery but went to pcp for annual physical Everything wnl
This spontaneous report was received from a nurse and refers to an unspecified number of patients of unknown age and gender. No information regarding the patient's medical history, concurrent conditions and concomitant therapies was provided. On unknown dates, the patients were vaccinated with improperly stored doses of M-M-R II (lot # L019989 and expiration date 01-JUN-2017, lot # L020189 and expiration date 03-JUN-2017, exact doses and route of administration were not reported). The vaccines were exposed to temperature of 105C for 32 hours, 8 minutes and to temperature of 0.6C for 16 hours. No previous temperature excursion was reported. No adverse effects were reported. No PQC (product quality complaint) was involved. This is one of several reports received from the same source. Additional information has been requested.
This spontaneous report was received from a nurse, referring to a patient of unknown age and gender. The patient's historical drugs, medical history, concomitant therapies, drugs allergies and concurrent conditions were not reported. On 14-NOV-2007, the patient was vaccinated with an improperly stored dose of VARIVAX lot # N001530, expiration date 13-JAN-2019, for prophylaxis (strength, dose, route and frequency were not reported). The PROQUAD was reconstituted with a properly stored sterile diluent (MERCK STERILE DILUENT) (lot # and expiration date were unknown). The temperature excursion was of 47°F to 50°F, during 35 minutes. A previous temperature excursion was not reported. A digital data logger was involved. No adverse effects were reported. Additional information is not expected. This is one of several reports received from  the same reporter.; Sender's Comments:  US-009507513-1801USA003525: US-009507513-1801USA003520: US-009507513-1801USA003521: US-009507513-1801USA003522: US-009507513-1801USA003523: US-009507513-1801USA003524: US-009507513-1801USA003526: US-009507513-1712USA013991: US-009507513-1801USA003612:
Body aches; Fever; This case was reported by a consumer via call center representative and described the occurrence of general body pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 11th February 2020, the patient received Shingrix. In February 2020, less than a week after receiving Shingrix, the patient experienced general body pain and fever. On an unknown date, the outcome of the general body pain and fever were not recovered/not resolved.   It was unknown if the reporter considered the general body pain and fever to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as an adult as per the vaccine indication. The patient received Shingrix and had body ache and fever.  The reporter asked how long would side effects usually last. The reporter did not consent to follow up.
inconsolable cry for over one hr;then altered sleep pattern for over 1wk;began few hr p/vax;no rx;
Anaphylaxis occurred within 5 minutes of administering MMR, IPV, and DTaP.  The leg in which MMR was given was red and swollen.  The patient was tachycardic, diaphoretic, wheezing, and we were unable to obtain a blood pressure.  Epinephrine was administered subcutaneously along with albuterol nebs and oxygen.  Initial oxygen saturation was 67%. 3/2/06 REceived medical records from hospital which revealed patient experienced VPS, hydrocephalus, Chiari malformation & s/p myelomeningocele repair, vocal cord paralysis, left hemiparesis, headaches & abdominal pain.  Shunt last revised 2003.  DX: headache in patient w/VP shunt.  4/4/06 Received medical records from PCP which revealed patient cared for at home by VNA & Mom who works f/t.  Receiving ST/OT/PT.  Failure to gain weight & Mom missed many appointments.  Moved from area & did not return until 2/06.  Mom/nurses do I/O cath qid, G-tube but is able to take oral.  Has trach but is off vent, able to speak & suction herself.  W/C bound.  Received vzx 2/1/06 & had anaphylaxis within 5 min w/resp distress, wheezes, poor air exchange, cyanosis, diaphoresis & tachycardia.  Given epi & nebs, bagged via trach & transported to ER/ss
Patient received 0.2mL of Pfizer purple cap COVID-19 vaccine. Patient's age was 10 years at the time and date of the incident and was outside the EUA for the Pfizer purple cap COVID-19 vaccine.   Clinic staff were not aware of this event until State notified clinic staff that state documentation review showed adult dose was documented in a pediatric immunization record.
Pt stated she was experiencing swelling at the injection site and had welts/hives around the injection site as well, starting approximately the day after injection. Pt has been using ice pack, benadryl, and ibuprofen to help with symptomatic relief, but symptoms still have not resolved and will be going
localized rxn to lt deltoid area @ inj site of DTAP;6cm induration & erythema;
On the arm I got the shot, down and to the side of my body , I had arm pain and the following day got a blister at that site; On the arm I got the shot, down and to the side of my body , I had arm pain and the following day got a blister at that site; This is a spontaneous report from a contactable nurse (patient). A 46-years-old female patient received first dose bnt162b2 (BNT162B2), intramuscular on Right arm on 22Dec2020 06:15 at SINGLE DOSE for covid-19 immunisation. Medical history included patient diagnosed with COVID-19. Concomitant medication included vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]), ergocalciferol (Vzinc (ZINCIT D), ) and multivitamin. The patient reported "on the arm i got the shot, down and to the side of my body, i had arm pain and the following day got a blister at that site" on 22Dec2020 12:00. No treatment received. The event outcome was recovered in Dec2020. The event was non-serious.  Information on the lot/batch number has been requested.
Itchyness on toes and tingling in fingers. Only lasted 10 or 15 minutes
headache where her head is pounding and feels like it is going to explode; has not had a menstrual cycle or period since Jul2020; but about 1 hour after vaccine administered menstrual cycle or period started with a vengeance and has worsened since then; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 48-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number: EN6205, and expiration date: 30Jun2021), via an unspecified route of administration, administered on the upper left arm on 03Mar2021 12:00 (at the age of 48-years-old), as first dose, single for COVID-19 immunisation. Medical history included ongoing thyroid disorder (thyroid) and ongoing seizure. Concomitant medications included levothyroxine (manufacturer unknown) 200 micrograms once daily, taken for thyroid disorder from an unspecified start date and ongoing (reported as roughly 6-8 months ago); and levetiracetam (KEPPRA) 1500 mg twice daily, taken for seizure from an unspecified start date and ongoing (reported as roughly 6-8 months ago). The patient did not received any other vaccines on the day of vaccination and within 4 weeks prior to the COVID vaccine. The patient has not had a menstrual cycle or period since Jul2020, but about 1 hour after vaccine was administered, menstrual cycle or period started with a vengeance and has worsened since then on 03Mar2021 13:00. Patient also had onset of headache where her head was pounding and feels like it is going to explode during call on 04Mar2021 (reported time of call was between 13:31 and 13:49). Patient asked if this event or a lot of events have been reported with the vaccine. At time of report, it was unknown if patient will or will not get second dose as scheduled. Patient did not consult physician nor urgent care for the events reported. Patient was not hospitalized as a result of the events. The outcome of menstrual disorder was not recovered and headache was unknown.  No follow-up attempts are possible. No further information is expected.